Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.98 USD | +1.38% | -6.95% | -42.07% |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 525M | Capitalization | 1B |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -29M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | 63.34M | Net cash position 2025 * | 76.49M | EV / Sales 2025 * | 1.76 x |
P/E ratio 2024 * |
-26.6
x | P/E ratio 2025 * |
-33.2
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.93% |
Latest transcript on AtriCure, Inc.
1 day | +1.33% | ||
1 week | -6.95% | ||
Current month | -14.28% | ||
1 month | -25.12% | ||
3 months | -37.20% | ||
6 months | -41.71% | ||
Current year | -42.07% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | -.--% | ||
0.03% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 20.7 | +0.07% | 46 383 |
24-05-08 | 20.69 | -5.40% | 555,131 |
24-05-07 | 21.87 | -1.04% | 448,375 |
24-05-06 | 22.1 | +5.79% | 1,234,925 |
24-05-03 | 20.89 | -5.99% | 961,862 |
Delayed Quote Nasdaq, May 09, 2024 at 10:37 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.07% | 1B | |
-4.92% | 183B | |
-0.17% | 108B | |
-3.37% | 67.51B | |
+4.67% | 50.67B | |
+9.27% | 44.7B | |
+2.41% | 40.95B | |
+4.98% | 26.8B | |
+0.88% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- ATRC Stock